These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1566282)

  • 1. Phenotypic and functional modifications of thymocytes during tumor growth.
    Lombardi D; Naso G; Ottavio L; Lenti L; Mardente S; Pontieri GM
    Thymus; 1992 Feb; 19(1):13-33. PubMed ID: 1566282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-cell recruitment from the thymus to the spleen in tumor bearing mice: phenotypical alteration and recruitment of thymocytes raised in a tumor bearing state.
    Tanaka K; Koga Y; Taniguchi K; Nomoto K
    Cancer Res; 1987 Apr; 47(8):2136-41. PubMed ID: 3493841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thymic involution and thymocyte phenotypic alterations induced by murine mammary adenocarcinomas.
    Fu Y; Paul RD; Wang Y; Lopez DM
    J Immunol; 1989 Dec; 143(12):4300-7. PubMed ID: 2592775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunosubversive role of PGE2 in tumor bearing mice.
    Ippoliti F; Sezzi ML; Bellelli L; Naso G; Pontieri GM
    Boll Ist Sieroter Milan; 1985; 64(1):25-34. PubMed ID: 3859302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of L3T4-positive T lymphocytes in the generation of anti-tumor immunity in the mouse.
    Yamamoto H; Takata M; Fujimoto S
    Jpn J Cancer Res; 1987 Feb; 78(2):176-84. PubMed ID: 2951356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro differentiation of T-cells capable of mediating the regression of established syngeneic tumors in mice.
    Shu S; Chou T; Rosenberg SA
    Cancer Res; 1987 Mar; 47(5):1354-60. PubMed ID: 3102046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melphalan-induced enhancement of antitumor immune reactivity in thymocytes of adult BALB/c mice bearing a large MOPC-315 tumor.
    Bartik MM; Takesue BY; Mokyr MB
    Cancer Res; 1987 Sep; 47(18):4848-55. PubMed ID: 3497711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular basis of immunologic interactions in adoptive T cell therapy of established metastases from a syngeneic murine sarcoma.
    Ward BA; Shu S; Chou T; Perry-Lalley D; Chang AE
    J Immunol; 1988 Aug; 141(3):1047-53. PubMed ID: 3260908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymic responses to antigen challenge. I. Tumor cells induced phenotypic and functional changes in vivo.
    Rollwagen FM; Kim KJ; Asofsky R
    Thymus; 1982 Sep; 4(5):279-85. PubMed ID: 6983745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Some characteristics of the cyclophosphamide-induced immunopotentiating cells in the spleen of mice bearing a large MOPC-315 tumor.
    Mokyr MB; Ye QW
    Cancer Res; 1985 Oct; 45(10):4932-9. PubMed ID: 4027979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotype of syngeneic tumor-specific cytotoxic T-lymphocytes and requirements for their in vitro generation from tumor-bearing host and immune spleens.
    Bear HD; Susskind BM; Close KA; Barrett SK
    Cancer Res; 1988 Mar; 48(6):1422-7. PubMed ID: 2964266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of fish oil and corn oil diets on prostaglandin-dependent and myelopoiesis-associated immune suppressor mechanisms of mice bearing metastatic Lewis lung carcinoma tumors.
    Young MR; Young ME
    Cancer Res; 1989 Apr; 49(8):1931-6. PubMed ID: 2522813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Release of immature cells from the thymus during solid tumor growth: identification by assay of TdT activity.
    Small M; Lasser-Weiss M; Daniel V
    J Immunol; 1979 Jul; 123(1):259-62. PubMed ID: 312875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of Lyt-2+ T-cells in the resistance of melphalan-cured MOPC-315 tumor bearers to a challenge with MOPC-315 tumor cells.
    Barker E; Mokyr MB
    Cancer Res; 1988 Sep; 48(17):4834-42. PubMed ID: 3261626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of Ia+ reticulum cell sarcoma (RCS) growth in syngeneic SJL/J mice. I. Inhibition of tumor growth by passive administration of L3T4 monoclonal antibody before or after tumor inoculation.
    Ohnishi K; Bonavida B
    J Immunol; 1987 Jun; 138(12):4524-9. PubMed ID: 2953807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrasuppressor cells that break oral tolerance are antigen-specific T cells distinct from T helper (L3T4+), T suppressor (Lyt-2+), and B cells.
    Kitamura K; Kiyono H; Fujihashi K; Eldridge JH; Green DR; McGhee JR
    J Immunol; 1987 Nov; 139(10):3251-9. PubMed ID: 3500210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for the functional binding in vivo of tumor rejection antigens to antigen-presenting cells in tumor-bearing hosts.
    Shimizu J; Zou JP; Ikegame K; Katagiri T; Fujiwara H; Hamaoka T
    J Immunol; 1991 Mar; 146(5):1708-14. PubMed ID: 1993850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Host reactivity against clonable tumor cells and the total tumor cell population, studied in a syngeneic murine lymphoma system.
    Gjedde SB
    Acta Pathol Microbiol Immunol Scand C; 1983 Apr; 91(2):101-8. PubMed ID: 6349250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Requirements for the generation of a Lyt-2+ T-cell proliferative response to a syngeneic tumor in the absence of L3T4+ T-cells.
    Kern DE; Klarnet JP; Cheever MA; Greenberg PD
    Cancer Res; 1990 Oct; 50(19):6256-63. PubMed ID: 2144789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulation by various nitrosoureas and its effect on the survival of the murine host bearing a syngeneic tumor.
    Nagarkatti M; Toney DM; Nagarkatti PS
    Cancer Res; 1989 Dec; 49(23):6587-92. PubMed ID: 2573418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.